Chinese infant formula manufacturer Synutra has posted a first-quarter loss as a decision to stop selling industrial milk powder hit sales.
The infant formula manufacturer said today (10 August) that net losses reached US$9.6m for the quarter ended 30 June against a $10.1m net profit in the same period of last year.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Synutra made an operating loss of $9.8m against an operating profit of $16.3m in the same quarter of the previous year.
Sales fell to $43.8m from $83.7m in the first quarter of its last financial year due to a decline in sales after Synutra decided to not enter into selling milk powder.
Synutra also said $16.6m of its sales moved from the June quarter into early July, which was due to a whey powder delivery timing from its French supplier.
Speaking about the industrial milk sales, CFO Donghao Yang said: “In the past, we have used these sales as a form of short-term financing. We are pleased to note that as our sales performance strengthened, we we were able to meet our short-term cash requirements.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHe added that the company’s French supplier will begin regular shipments in August.
